The possibility of using freely circulating DNA blood plasma in preoperative diagnosis of thyroid tumors

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND. The feasibility of using molecular genetic markers for the diagnosis of thyroid tumors and the impact on the prognosis of thyroid cancer are being actively investigated. The most interesting are genes, the detection of which is associated not only with thyroid cancer, but also with a more aggressive course of the disease. The ability to diagnose the molecular profile of minimally invasive methods with the study of freely circulating DNA tumor tissue in blood plasma is a modern trend of medicine. AIMS: to evaluate the frequency of somatic mutations in the «hot spots» of BRAF, KRAS, KRAS, EIF1AX and TERT genes in circulating DNA of blood plasma. MATERIALS AND METHODS. Samples of DNA, extracted from the removed tumor and non-tumor thyroid tissue, were tested for the presence of somatic mutations in hot spots of the genes BRAF, KRAS, NRAS, TERT, and EIF1AX and then in identifying mutations and testing appropriate samples of free circulating DNA in blood plasma. RESULTS. mutations in the» hot spots «of the BRAF gene (exon 15, codon area 600-601) were found in 54 patients, mutations in the» hot spots « of the NRAS gene (exon 3, codon 61) – in 12 patients; mutations in the hot spots of the KRAS, TERT and EIF1AX genes were not detected. In freely circulating blood plasma DNA, BRAF gene mutations were detected in 1 case, NRAS gene mutations were detected in 1 case. CONCLUSIONS. the use of freely circulating DNA of blood plasma in the testing of the studied sample did not show the feasibility for the diagnosis of thyroid tumors.

Full Text

Restricted Access

About the authors

Vera A. Kachko

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: VeraF246@gmail.com

postgraduate

Moscow

Vladimir E. Vanushko

Endocrinology Research Centre

Email: vanushko@gmail.com

MD, PhD

Moscow

Nadezhda M. Platonova

I.M. Sechenov First Moscow State Medical University (Sechenov University); Endocrinology Research Centre

Email: doc-platonova@inbox.ru

MD, PhD

Moscow

Aleksandr Yu. Abrosimov

Endocrinology Research Centre

Email: nikitarusskikh@mail.ru

MD, PhD

Moscow

Ekaterina N. Tely`sheva

Russian Research Center of Roentgenoradiology

Email: telisheva_k@mail.ru

researcher

Moscow

Galina P. Snigireva

Russian Research Center of Roentgenoradiology

Email: sni_gal@mail.ru

Dr, PhD

Moscow

Anatoliy Nikolaevich Tyul'pakov

ФГБУ "Национальный медицинский исследовательский центр эндокринологии" Минздрава России

Email: ant@endocrincentr.ru

д.м.н. Заведующий отделением наследственных эндокринопатий детского возраста

117036, Москва, ул. Дм. Ульянова, 11 ---------------------------------------- 11, Дм.Ульянова стрит, Моссоу, 117036

Il'ya Viktorovich Kim

Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр эндокринологии" Министерства здравоохранения Российской Федерации

Email: ilyakim@yandex.ru

к.м.н., ведущий научный сотрудник отдела хирургии

117036, Москва. улица Дмитрия Ульянова, дом 11

References

  1. Бельцевич Д.Г., Ванушко В.Э., Румянцев П.О. и др. Российские клинические рекомендации по диагностике и лечению высокодифференцированного рака щитовидной железы у взрослых, 2017 год. // Эндокринная хирургия. – 2017. – Т. 11. – №1. – С. 6–27. doi: 10.14341/serg201716-27. [Beltsevich DG, Vanushko VE, Rumyantsev PO, et al. 2017 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment. Endocrine Surgery. 2017;11(1):6 -27. doi: 10.14341/serg201716 -27.(In Russ).]
  2. Ma M, Zhu H, Zhang C, Sun X, Gao X, Chen G. “Liquid biopsy” – ctDNA detection with great potential and challenges. Ann Transl Med. 2015 Sep; 3 (16): 235. doi: 10.3978/j.issn.2305-5839.2015.09.29.
  3. Diaz LA Jr, Bardelli A. Liquid Biopsies: Genotyping Circulating Tumor DNA. J Clin Oncol. 2014 Feb 20; 32 (6): 579–86. doi: 10.1200/JCO.2012.45.2011.
  4. Beije N, Helmijr JC, Weerts MJA, Beaufort CM, Wiggin M, Marziali A et al. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases. Mol Oncol. 2016 Dec; 10 (10): 1575–84. doi: 10.1016/j.molonc.2016.10.001.
  5. Захаренко А. А., Зайцев Д. А., Беляев М. А., Трушин А. А., Тен О. А., Натха А. С. Возможности жидкой биопсии при раке желудка. Вопросы онкологии. 2016; 62 (4): 379–85.
  6. Тамкович С. Н., Власов В. В., Лактионов П. П. Циркулирующие ДНК крови и их использование в медицинской диагностике. Молекулярная биология. 2008; 42 (1): 12–23.
  7. Васильева И. Н., Беспалов В. Г. Роль внеклеточной ДНК в возникновении и развитии злокачественных опухолей и возможности ее использования в диагностике и лечении онкологических заболеваний. Вопросы онкологии. 2013; 59 (6): 673–81.
  8. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008 Sep; 14 (9): 985–90. doi: 10.1038/nm.1789.
  9. Holdhoff M, Schmidt K, Donehower R, Diaz LA. Analysis of circulating tumor DNA to confirm somatic KRAS mutations. J Natl Canc Inst. 2009; 101 (18): 1284-–5. doi: 10.1093/jnci/djp240.
  10. Chen KZ, Lou F, Yang F, Zhang JB, Ye H, Chen W et al. Circulating tumor DNA detection in early-stage non-small cell-lung cancer patients by targeted sequencing. Sci Rep. 2016 Aug 24; 6: 31985. doi: 10.1038/srep31985.
  11. Rachiglio AM, Abate RE, Sacco A, Pasquale R, Fenizia F, Lambiase M et al. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Oncotarget. 2016 Oct 11; 7 (41): 66595–605. doi: 10.18632/oncotarget.10704.
  12. Tu M, Chia D, Wei F, Wong D. Liquid biopsy for etection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB). Analyst. 2016 Jan 4; 141 (2): 393–402. doi: 10.1039/c5an01863c.
  13. Белоусова А. В., Дрозд О. В., Зарецкий А. Р. Мутационно-специфическая полимеразная цепная реакция для анализа мутаций в «горячих точках» генов K-Ras и B-Raf в биологических образцах онкологических больных. В сб.: Тезисы конференции «Современные принципы диагностики и лечения колоректального рака», посвященной памяти проф. В. И. Кныша; 26–27 мая 2011 г.; Москва. М.: 2011. с. 16.
  14. Е. Н. Телышева, Г. П. Снигирева. Аназиз соматических мутаций в генах Ras- каскада свободно циркулирующей ДНК плазмы крови пациентов с колоректальным раком методом усиленной аллель-специфической ПЦР в «реальном времени»..Вестник РГМУ 2017; 4: 14-20
  15. Качко В.А., Семкина Г.В., Абросимов А.Ю. и др. Диагностика новообразований щитовидной железы Эндокринная хирургия, 2018, том 12, №3, С.109-127 [Kachko VA, Semkina GV, Abrosimov AY, Platonova NM, Vanushko VE. Diagnosis of thyroid neoplasms: state of the art on 2018. Endocrine Surgery. 2018;12(3):109-127. doi: https://doi.org/10.14341/serg9977 (In Russ).]
  16. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184-199. doi: 10.1038/nrc3431.
  17. Younis E. Oncogenesis of Thyroid Cancer. Asian Pac J Cancer Prev. 2017;18(5):1191–1199. Published . doi: 10.22034/APJCP.2017.18.5.1191
  18. Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine (Baltimore) 2012;91:274–286.
  19. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. Jama. 2013; 309:1493–1501.
  20. Howell GM, Hodak SP, Yip L. RAS mutations in thyroid cancer. Oncologist. 2013;18(8):926-32.
  21. Gandolfi G., Ragazzi M., Frasoldati A., Piana S., Ciarrocchi A., Sancisi V. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur. J. Endocrinol. 2015;172:403–413. doi: 10.1530/EJE-14-0837.
  22. Liu X., Qu S., Liu R., Sheng C., Shi X., Zhu G., Murugan A.K., Guan H., Yu H., Wang Y., et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J. Clin. Endocrinol. Metab. 2014;99:E1130–E1136. doi: 10.1210/jc.2013-4048.
  23. Liu, T., Yuan, X., & Xu, D. Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications. Genes,2016; 7(7), 38. doi: 10.3390/genes7070038.
  24. Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocrine-Related Cancer. 2013; 20:603–610. [PubMed: 23766237
  25. Liu R. and Xing M., TERT Promoter Mutations in Thyroid Cancer Endocr Relat Cancer. 2016 March ; 23(3): R143–R155. doi: 10.1530/ERC-15-0533.]
  26. Jin A., Xu J., Wang Y..The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer. Medicine (Baltimore). 2018 Jul;97(29):e11548. doi: 10.1097/MD.0000000000011548.
  27. Abdullah MI, Junit SM, Ng KL, et all. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci. 2019;16(3):450–460. Published 2019 Feb 28. doi: 10.7150/ijms.29935
  28. Karunamurthy A, Panebianco F, J Hsiao S, et al. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules. Endocr Relat Cancer. 2016;23(4):295-301. doi: 10.1530/ERC-16-0043
  29. Качко В.А., Зарецкий А.Р., Ванушко В.Э., и др. Тестирование соматических мутаций: роль в дифференциальной диагностике новообразований щитовидной железы. Эндокринная хирургия, 2019, Т. 13, №1, С.26-41. doi: https://doi.org/10.14341/serg10181 [Kachko VA, Zaretsky AR, Vanushko VE, Platonova NM, Abrosimov AYu, Semkina GV Somatic mutation testing: the role in differential diagnosis of thyroid neoplasms. Endocrine Surgery. 2019;13(1):26 -41. doi: https://doi.org/10.14341/serg10181 (In Russ).]
  30. Качко В.А., Ванушко В.Э., Платонова Н.М. Прогностическое значение тестирования соматических мутаций и различных методов лечения при высокодифференцированном раке щитовидной железы низкого риска Эндокринная хирургия, 2019, Т. 13, №2 doi:https://doi.org/10.14341/serg10220 [Kachko VA, Vanushko VE, Platonova NM. Prognostic value of somatic mutation testing and different methods of treatment of low -risk differentiated thyroid cancer. Endocrine surgery. 2019;13(2). doi: https://doi.org/10.14341/serg10220. (In Russ).]
  31. COSMIC [Internet]. Catalogue of Somatic Mutations In Cancer [cited 2018 Dec 12]. Available from: https://cancer.sanger.ac.uk/cosmic
  32. EnsEMBL [Internet]. Genome browser [cited 2018 Dec 12]. Available from: http://www.ensembl.org

Statistics

Views

Abstract: 25

Cited-by

CrossRef: 5

  1. Dolgikh EA, Kusakin PG, Kitaeva AB, Tsyganova AV, Kirienko AN, Leppyanen IV, et al. Mutational analysis indicates that abnormalities in rhizobial infection and subsequent plant cell and bacteroid differentiation in pea (Pisum sativum) nodules coincide with abnormal cytokinin responses and localization. Annals of Botany. 2020;125(6):905. doi: 10.1093/aob/mcaa022
  2. Gorshkov AP, Tsyganova AV, Vorobiev MG, Tsyganov VE. The Fungicide Tetramethylthiuram Disulfide Negatively Affects Plant Cell Walls, Infection Thread Walls, and Symbiosomes in Pea (Pisum sativum L.) Symbiotic Nodules. Plants. 2020;9(11):1488. doi: 10.3390/plants9111488
  3. Dolgikh AV, Rudaya ES, Dolgikh EA. Identification of BELL Transcription Factors Involved in Nodule Initiation and Development in the Legumes Pisum sativum and Medicago truncatula. Plants. 2020;9(12):1808. doi: 10.3390/plants9121808
  4. Tsyganova AV, Seliverstova EV, Brewin NJ, Tsyganov VE. Bacterial release is accompanied by ectopic accumulation of cell wall material around the vacuole in nodules of Pisum sativum sym33-3 allele encoding transcription factor PsCYCLOPS/PsIPD3. Protoplasma. 2019;256(5):1449. doi: 10.1007/s00709-019-01383-1
  5. Tsyganov VE, Tsyganova AV. Symbiotic Regulatory Genes Controlling Nodule Development in Pisum sativum L.. Plants. 2020;9(12):1741. doi: 10.3390/plants9121741

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2019 Kachko V.A., Vanushko V.E., Platonova N.M., Abrosimov A.Y., Tely`sheva E.N., Snigireva G.P., Tyul'pakov A.N., Kim I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies